Microorganisms offer a wide array of useful metabolites and products ranging from environmentally important biofuels
[1,2], industrially important enzymes [3,4], agriculturally important biofertilizers [5,6] and biopesticides [7,8], etc. Apart
from that, microorganisms are a natural source of a plethora of medically significant molecules like antibiotics [9–11],
anticancer agents [12,13], antivirals [14,15], etc. Also, the utilization of microorganisms for commercial production of
industrially important compounds is inherently advantageous. This can be attributed to the literally unending metabolic
diversity of microbes, their shorter life spans, amenability to genetic modification, relatively simpler cultivation requirements,
etc. [16]. Moreover, due to the ever-increasing need for novel therapeutic agents as well as the stress on natural
products, the microbes and fermentation industry are gaining importance day by day [11,17]. Another major force providing
impetus for looking for novel microbial metabolites (especially in the field of medicine), is the ever increasing challenge
of emergence of drug resistance in pathogenic microorganisms which includes drug resistant bacteria, fungi, viruses
as well as protozoa [11,18–20]. Moreover, the recent coronavirus pandemic, caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has practically caught us unaware with respect to our preparedness for any novel and
emerging infection. So, exploring the microbial metabolic diversity for therapeutic as well as other potential uses is certainly
the need of hour.